Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30022223HIVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS30022224HIVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS30022225HIVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS30022226HIVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS20003385HPVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS20047165HPVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS20037865HPVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS20043928HPVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS44014774HTLV-1ENSG00000198793.14protein_codingMTORYesNo2475P42345
TCGA Plot Options
Drug Information
GeneMTOR
DrugBank IDDB11962
Drug NameGSK-1059615
Target IDBE0002386
UniProt IDP42345
Regulation Typeinhibitor
PubMed IDs28881606; 30765226
CitationsXie J, Li Q, Ding X, Gao Y: GSK1059615 kills head and neck squamous cell carcinoma cells possibly via activating mitochondrial programmed necrosis pathway. Oncotarget. 2017 Feb 7;8(31):50814-50823. doi: 10.18632/oncotarget.15135. eCollection 2017 Aug 1.@@Bei S, Li F, Li H, Li J, Zhang X, Sun Q, Feng L: Inhibition of gastric cancer cell growth by a PI3K-mTOR dual inhibitor GSK1059615. Biochem Biophys Res Commun. 2019 Mar 26;511(1):13-20. doi: 10.1016/j.bbrc.2019.02.032. Epub 2019 Feb 11.
GroupsInvestigational
Direct ClassificationBipyridines and oligopyridines
SMILESO=C1NC(=O)C(S1)=CC1=CC=C2N=CC=C(C3=CC=NC=C3)C2=C1
Pathways
PharmGKB
ChEMBLCHEMBL3544966